viloxazine hydrochloride

FDA Drug Profile — QELBREE

viloxazine hydrochloride is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand name including QELBREE. Available dosage form: capsule, extended release.

Drug Details

Generic Name
viloxazine hydrochloride
Brand Names
QELBREE
Application Number
NDA211964
Sponsor
Catalent Pharma Solutions, LLC
NDC Codes
6
Dosage Forms
CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
VILOXAZINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Qelbree is indicated for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older. Qelbree is a selective norepinephrine reuptake inhibitor indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients 6 years and older ( 1 )